-

Victory! AHF, 100 Organizations Kill Gilead’s Greedy Drug Price Hikes

Groups welcome reversal of Gilead’s price gouging decision that would have resulted in fewer people with HIV getting access to lifesaving treatment.

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) was victorious killing Gilead Sciences’ plan to institute high-single digit price hikes for several of its HIV medications, hikes that would have gutted the nation’s AIDS Drug Assistance Programs (ADAPs).

AHF sent a letter signed by over 100 organizations to Gilead CEO Daniel O’Day demanding the company hold off on the price hikes. The following day, Gilead announced that it agreed not to boost prices on its key HIV medications, according to STAT News.

Share

Last week, following months of negotiations between Gilead and state ADAP programs, AHF sent a letter signed by over 100 organizations nationwide to Gilead CEO Daniel O’Day demanding the company hold off on the proposed hikes. The following day, Gilead announced that it had agreed not to boost prices on its key HIV medications, according to STAT News.

ADAPs, a national network of state AIDS drug programs, are a lifeline for low-income patients. The price hike would have meant ADAPs would have furnished fewer prescriptions to those most in need.

Unfortunately, Gilead’s initial decision to make life-saving therapeutics more expensive for ADAPs was not a one-off but follows a pattern under the leadership of Gilead’s CEO, Daniel O’Day.

O’Day ruthlessly seeks to boost profits by restricting access to Gilead’s HIV medicines. From patent manipulation to curtailing patient assistance programs, O’Day has proven that drug giants do not need to innovate to make money. Under his tenure, Gilead has put up multiple roadblocks to make it harder for medically underserved Americans to attain their medications. O’Day has had one goal – maximizing profits of the older drugs in Gilead’s portfolio instead of investing in the breakthrough HIV therapeutics of the future.

AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 2.6 million individuals across 49 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, visit us online at AIDShealth.org, find us on Facebook, and follow us on Instagram, Twitter, and TikTok.

Contacts

MEDIA CONTACTS:
John Hassell,
AHF National Director of Advocacy
1.202.774.4854 mobile. john.hassell@ahf.org

Ged Kenslea, Sr. Director, Communications, AHF
1.323.791.5526 mobile ged.kenslea@ahf.org

AIDS Healthcare Foundation


Release Summary
Victory! AHF, 100 Organizations Kill Gilead’s Greedy Drug Price Hikes
Release Versions

Contacts

MEDIA CONTACTS:
John Hassell,
AHF National Director of Advocacy
1.202.774.4854 mobile. john.hassell@ahf.org

Ged Kenslea, Sr. Director, Communications, AHF
1.323.791.5526 mobile ged.kenslea@ahf.org

Social Media Profiles
More News From AIDS Healthcare Foundation

AHF Hails Introduction of Protect 340B Act of 2026

WASHINGTON--(BUSINESS WIRE)--AHF Hails Introduction of Protect 340B Act of 2026...

AHF Urges African Nations to Take Charge of Medicines Regulation

KIGALI, Rwanda--(BUSINESS WIRE)--With more than 20 African Union Member States yet to ratify the African Medicines Agency (AMA) Treaty, AIDS Healthcare Foundation (AHF) calls on African governments to accelerate ratification and regulatory harmonisation to expand access to affordable medicines and unlock Africa’s pharmaceutical manufacturing potential.The call comes as AMA convenes its inaugural week in Kigali, Rwanda, from 25–30 October 2026, against a backdrop of continued dependence on import...

Treatment = Life: AHF Reaches 2 Million Patients in Care in Africa

KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) has surpassed 2 million patients in care across 15 African countries, marking a historic achievement 25 years after beginning its first programs outside the United States in South Africa and Uganda. With programs in four additional countries expected to launch in 2027, AHF is recognizing the communities and partnerships behind this progress while calling for urgent action to close persistent gaps in the HIV response. AHF’s work...
Back to Newsroom